StonvexLoading…
StonvexStonvexStonvexCore line items from NDSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $2.79B | $2.69B | $2.63B | $2.59B |
Operating Income | $711.73M | $674.00M | $672.76M | $702.36M |
Net Income | $484.47M | $467.28M | $487.49M | $513.10M |
EPS (Diluted) | $8.51 | $8.11 | $8.46 | $8.81 |
Total Assets | $5.92B | $6.00B | $5.25B | $3.82B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $108.44M | $115.95M | $115.68M | $163.46M |
Free Cash Flow OCF − CapEx | $661.12M | $491.78M | $606.70M | $461.70M |
Shares Outstanding | 55.92M | 57.20M | 57.01M | 57.11M |